Minimal Effective Dosage of Recombinant Human Erythropoietin in Spinal Surgery
- 1 July 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 412 (412) , 71-76
- https://doi.org/10.1097/01.blo.0000069004.56218.1e
Abstract
Preoperative autologous blood donation is one of the most widely used methods of autotransfusion. However securing a predetermined amount of blood (3 units of whole blood) may be difficult in patients with a low preoperative hematocrit. To determine the minimum effective pretreatment dosage of recombinant human erythropoietin required to secure an adequate amount of preoperative blood for autologous transfusion during posterior decompression and instrumentation fusion using the pedicle screw-rod system in the lumbar spine, a prospective randomized clinical trial was done. Forty-five patients who had a preoperative hematocrit less than 40% were selected and were divided blindly into three groups. Fifty units per kilogram of recombinant human erythropoietin seems to be the minimal effective dosage for securing an adequate amount of preoperative autologous blood donation.This publication has 10 references indexed in Scilit:
- Érythropoïétine et hypertension artérielle chez l'insuffisant rénal chroniqueLa Revue de Médecine Interne, 1995
- Comparison of Autotransfusion with Homologous Transfusion in Spinal SurgeryJournal of the Korean Orthopaedic Association, 1995
- Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patientsTransfusion, 1993
- The effect of oral iron supplementation on erythropoiesis in autologous blood donorsTransfusion, 1992
- Optimal Route of Administration of Erythropoietin in Chronic Renal Failure Patients: Intravenous versus SubcutaneousActa Haematologica, 1992
- Autologous blood transfusion with recombinant human erythropoietin in heart operationsThe Annals of Thoracic Surgery, 1991
- Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin TherapyNew England Journal of Medicine, 1989
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Hemodynamics in Hemodialysis Patients Treated with Recombinant Human ErythropoietinPublished by S. Karger AG ,1988
- Safety of autologous blood donation prior to elective surgery for a variety of potentially “high‐risk” patientsTransfusion, 1983